These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3584 related articles for article (PubMed ID: 6824061)

  • 1. Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells.
    Gyi KK; Wrathall JR
    Am J Pathol; 1983 Feb; 110(2):135-47. PubMed ID: 6824061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
    Silagi S; Calvelli TA
    Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
    Newcomb EW; Silverstein SC; Silagi S
    J Cell Physiol; 1978 May; 95(2):169-77. PubMed ID: 306389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.
    Silagi S; Beju D; Wrathall J; Deharven E
    Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3443-7. PubMed ID: 4343973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.
    Hsieh CT; Luo YH; Chien CS; Wu CH; Tseng PC; Chiou SH; Lee YC; Whang-Peng J; Chen YM
    J Immunother; 2016 May; 39(4):153-9. PubMed ID: 27023059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 7. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
    J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of 5-bromodeoxyuridine on the growth and morphology of transformed rat liver cells.
    Avdalovic N; Weibel J; Diamond L
    J Cell Physiol; 1980 Jul; 104(1):83-96. PubMed ID: 7440648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions.
    Wrathall JR; Newcomb EW; Balint R; Zeitz L; Silagi S
    J Cell Physiol; 1975 Dec; 86 Suppl 2(3 Pt 2):581-92. PubMed ID: 811676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
    Rosenthal SL; Zucker D; Davidson RL
    J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma.
    Lee TH; Cho YH; Lee JD; Yang WI; Shin JL; Lee MG
    Immunol Lett; 2006 Jul; 106(1):19-26. PubMed ID: 16647143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of bromodeoxyuridine sensitivity of cultured cells from melanoma metastases.
    Poot M; Hiller KH; Heimpel S; Schuster A; Köhler J; Hoehn H
    Cytometry; 1995 Sep; 21(1):62-7. PubMed ID: 8529473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.
    Li XH; Paulus G; Atassi G; Buyssens N
    Am J Pathol; 1984 Jun; 115(3):403-11. PubMed ID: 6731586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.
    Christman JK; Silagi S; Newcomb EW; Silverstein SC; Acs G
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):47-50. PubMed ID: 123336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction (or stimulation) of prolactin and growth hormone production in a rat pituitary tumor cell line by bromodeoxyuridine.
    Cohen H; Andre J; Grenot C; Guillaumot P; Pascal O
    Endocrinology; 1982 Feb; 110(2):421-7. PubMed ID: 6799272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
    Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
    Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 180.